Tuesday November 24 2009 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

«Angiofibroma

Below is an extended Angiofibroma patents listing. Click here to return to the Angiofibroma main in depth entry.

Patents :

US Patent No.Title
7517901 p38 MAP kinase inhibitors and methods for using the same
7547781 Quinazoline based EGFR inhibitors containing a zinc binding moiety
7550141 Methods for imaging tumor vasculature using conjugates that bind to aminophospholipids
7550143 Methods for generating stably linked complexes composed of homodimers, homotetramers or dimers of dimers and uses
7553876 Polycationic compounds and uses thereof
7556809 Active antiangiogenic therapy
7560551 Aurora kinase modulators and method of use
7563787 Substituted pyrazole compounds
7563799 Substituted pyrazolo[3,4-D]pyrimidines as p38 map kinase inhibitors
7563800 Substituted pyrazolo[3,4-D]pyrimidines as p38 map kinase inhibitors
7566449 Method and composition for inhibition of angiogenesis using antagonists based on MMP-9 and .beta.1 integrins
7547703 Indoline derivatives substituted in the 6-position, their preparation and their use as medicaments
7538088 Method for inhibiting angiogenesis by administration of the extracellular domain of D1-1 polypeptide
7537773 Chemodenervating pharmaceutical as anti-inflammatory agent
7521056 Stably tethered structures of defined compositions with multiple functions or binding specificities
7521424 Albumin fusion proteins
7524816 Peptides and supported peptides for treating skin diseases
7527787 Multivalent immunoglobulin-based bioactive assemblies
7528165 Indole compounds
7528236 Humanized anti-beta7 antagonists and uses therefor
7531310 Methods of diagnosing Crohn's disease by measuring expression level of RNA encoding human G-protein coupled receptor, HGPRBMY11
7531553 Heterocyclic compounds and methods of use
7534428 Antibodies to tumor necrosis factor receptors 6.alpha. and 6.beta.
7534866 Methods and compositions for generating bioactive assemblies of increased complexity and uses
7566708 Substituted pyrazolo{3,4-D}pyrimidines as p38 map kinase inhibitors
7569384 Albumin fusion proteins
7597886 Tumor necrosis factor-gamma
7598348 Adiponectin receptor variant, AdipoR2v2
7601694 CLK-peptide and SLK-peptide
7601726 Substituted pyrazolo[3,4-d]pyrimidines as p38 MAP kinase inhibitors
7605235 Anti-tissue factor antibodies and compositions
7608603 Substituted pyrazolo[3,4-D]pyrimidines as p38 MAP kinase inhibitors
7608635 Pyrazole compounds that modulate HSP90 activity
7611704 Compositions and methods for treating viral infections using antibodies and immunoconjugates to aminophospholipids
7612180 Humanized L243 antibodies
7615223 Selected immunoconjugates for binding to aminophospholipids
7595051 Methods of treating neovascular glaucoma, macular degeneration and capillary proliferation with alphavbeta3-specific antibodies
7595038 Methods of treatment using antibodies to follistatin-3
7592466 Ureas having antiangiogenic activity
7572442 Selected antibody compositions for binding to aminophospholipids
7572448 Combined cancer treatment methods using selected antibodies to aminophospholipids
7572794 Anthranilamide pyridinureas as vascular endothelial growth factor (VEGF) receptor kinase inhibitors
7572821 Compounds for the treatment of proliferative disorders
7575582 Apparatus for deployment of micro-coil using a catheter
7578826 Apparatus for deployment of micro-coil using a catheter
7585841 Methods and compositions useful for modulation of angiogenesis using tyrosine kinase Src
7585967 Nucleic acid compounds for inhibiting angiogenesis and tumor growth
7588760 Antagonists specific for denatured collagen and methods of using same
7592010 Albumin fusion proteins
7615565 VEGFR-2 and VEGFR-3 inhibitory anthranilamide pyridines

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.